Drreddys Laboratories | RDY - Fremdkapital





Fremdkapital Veränderung Datum
ANI Pharmaceuticals USD 286M 5.84M 2026-03
Aurora Cannabis CAD 18.13M 15.07M 2026-03
Bayer EUR 30.68B 1.15B 2026-03
Canopy Growth CAD 217.12M 7.87M 2026-03
Cipla INR 3.82B 840.2M 2026-03
Drreddys Laboratories INR 12.2B 12.07B 2026-03
GlaxoSmithKline GBP 14.01B 696M 2026-03
Hikma Pharmaceutical USD 1.49B 692M 2025-12
Lonza CHF 3.88B 323M 2025-12
Novartis USD 37.45B 7.86B 2026-03
Pacira USD 367.66M 4.53M 2026-03
Phibro Animal Health USD 597.68M 5.92M 2026-03
Prestige Brands USD 1.01B 40.28M 2026-03
Richter Gedeon HUF 15.07B 75M 2026-03
Sun Pharmaceuticals INR 3.93B 309.9M 2026-03
Supernus Pharmaceuticals USD 400.38M 21.13M 2022-03
Teva Pharmaceutical Industries USD 14.02B 971M 2026-03